Benitec Biopharma BNTC
NASDAQ BNTC
$9.94 +0.19 (+1.95%)
As of: Sep 30, 2026 · 1:53 PM EDT

Benitec Biopharma Inc. (BNTC) Capital Expenditures (2020 - 2025)

Updated

Benitec Biopharma's Capital Expenditures came in at $105,000 for FY2026 (year ended Jun 30, 2026), up 483.3% from $18,000 in FY2025.

Analysis

Benitec Biopharma Inc. (BNTC) Capital Expenditures (2020 - 2025) Analysis & Trends

Going back to FY2019, Benitec Biopharma's Capital Expenditures data covers 8 fiscal years.

  • Capital Expenditures carries a five-year compound annual growth rate of -13.8% (FY2021 to FY2026).
  • The five-year range for annual Capital Expenditures is $1,000 (FY2023) to $179,000 (FY2024).
  • Per Business Quant, earlier fiscal years put Capital Expenditures at $18,000 in FY2025 (-89.9%), $179,000 in FY2024, $1,000 in FY2023 (-92.3%) and $13,000 in FY2022 (-94.1%).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 6,000.00
Jun 30, 2023 1,000.00
Jun 30, 2022 13,000.00
Jun 30, 2021 -141,000.00
Mar 31, 2021 15,000.00
Dec 31, 2020 174,000.00
Sep 30, 2020 173,000.00
Jun 30, 2020 13,000.00
API Access

Benitec Biopharma Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BNTC&period=max&api_key=YOUR_API_KEY